Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 144

Related Citations for PubMed (Select 16455829)

1.

C-reactive protein levels and clinically important predictive outcomes in stable COPD patients.

de Torres JP, Cordoba-Lanus E, López-Aguilar C, Muros de Fuentes M, Montejo de Garcini A, Aguirre-Jaime A, Celli BR, Casanova C.

Eur Respir J. 2006 May;27(5):902-7. Epub 2006 Feb 2.

2.

High value of combined serum C-reactive protein and BODE score for mortality prediction in patients with stable COPD.

Liu SF, Wang CC, Chin CH, Chen YC, Lin MC.

Arch Bronconeumol. 2011 Sep;47(9):427-32. doi: 10.1016/j.arbres.2011.04.011. Epub 2011 Aug 6. English, Spanish.

3.

[Systemic inflammation among stable ex smokers with chronic obstructive pulmonary disease].

Morales S A, Dreyse D J, Díaz P O, Saldías P F, Carrasco M, Lisboa B C.

Rev Med Chil. 2010 Aug;138(8):957-64. doi: /S0034-98872010000800003. Epub 2010 Nov 26. Spanish.

4.

[Correlation among the levels of C-reactive protein and interleukin-18, quality of life, and lung function in patients with chronic obstructive pulmonary disease].

Long H, Luo H, Chen P, Li Y.

Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2011 Nov;36(11):1090-6. doi: 10.3969/j.issn.1672-7347.2011.11.010. Chinese.

5.

The relationship between C-reactive protein and prognostic factors in chronic obstructive pulmonary disease.

Agarwal R, Zaheer MS, Ahmad Z, Akhtar J.

Multidiscip Respir Med. 2013 Sep 28;8(1):63. doi: 10.1186/2049-6958-8-63.

6.

C-reactive protein levels and survival in patients with moderate to very severe COPD.

de Torres JP, Pinto-Plata V, Casanova C, Mullerova H, Córdoba-Lanús E, Muros de Fuentes M, Aguirre-Jaime A, Celli BR.

Chest. 2008 Jun;133(6):1336-43. doi: 10.1378/chest.07-2433. Epub 2008 Mar 13.

PMID:
18339787
7.

[C-Reactive protein levels in patients with chronic obstructive pulmonary disease].

Díaz O, Parada A, Ramos C, Klaassen J, Díaz JC, Andresen M, Lisboa C, Saldías F.

Rev Med Chil. 2012 May;140(5):569-78. doi: 10.4067/S0034-98872012000500003. Spanish.

8.

Correlation between serum biomarkers and BODE index in patients with stable COPD.

Liu SF, Chin CH, Wang CC, Lin MC.

Respirology. 2009 Sep;14(7):999-1004. doi: 10.1111/j.1440-1843.2009.01608.x.

PMID:
19740260
9.

Inflammatory biomarkers and exacerbations in chronic obstructive pulmonary disease.

Thomsen M, Ingebrigtsen TS, Marott JL, Dahl M, Lange P, Vestbo J, Nordestgaard BG.

JAMA. 2013 Jun 12;309(22):2353-61. doi: 10.1001/jama.2013.5732.

PMID:
23757083
10.

[C-reactive protein level and the correlation between lung function and CRP levels in patients with chronic obstructive pulmonary diseases].

Wu SJ, Chen P, Jiang XN, Liu ZJ.

Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2005 Aug;30(4):444-6. Chinese.

11.
12.

C-reactive protein levels are raised in stable Chronic obstructive pulmonary disease patients independent of smoking behavior and biomass exposure.

Aksu F, Capan N, Aksu K, Ofluoğlu R, Canbakan S, Yavuz B, Akin KO.

J Thorac Dis. 2013 Aug;5(4):414-21. doi: 10.3978/j.issn.2072-1439.2013.06.27.

13.

Associations between BODE index and systemic inflammatory biomarkers in COPD.

Gaki E, Kontogianni K, Papaioannou AI, Bakakos P, Gourgoulianis KI, Kostikas K, Alchanatis M, Papiris S, Loukides S.

COPD. 2011 Dec;8(6):408-13. doi: 10.3109/15412555.2011.619599.

PMID:
22149400
14.

Systemic effects of nocturnal hypoxemia in patients with chronic obstructive pulmonary disease without obstructive sleep apnea syndrome.

Mueller Pde T, Gomes MD, Viegas CA, Neder JA.

J Bras Pneumol. 2008 Aug;34(8):567-74. English, Portuguese.

15.

Body mass and fat-free mass indices in COPD: relation with variables expressing disease severity.

Ischaki E, Papatheodorou G, Gaki E, Papa I, Koulouris N, Loukides S.

Chest. 2007 Jul;132(1):164-9. Epub 2007 May 15.

PMID:
17505043
16.

[Characteristics of stable chronic obstructive pulmonary disease related to systemic inflammation].

Solanes I, Bolíbar I, Llauger MA, Medrano C, Peiró M, Fraga M, Pou MA, Giner J, Freixas M, Plaza V; en nombre del Grupo de Investigación del Proceso EPOC.

Med Clin (Barc). 2012 Oct 20;139(10):430-6. doi: 10.1016/j.medcli.2012.03.033. Epub 2012 Jul 4. Spanish.

PMID:
22766062
17.

Changes in the BODE index, exacerbation duration and hospitalisation in a cohort of COPD patients.

Bu XN, Yang T, Thompson MA, Hutchinson AF, Irving LB.

Singapore Med J. 2011 Dec;52(12):894-900.

18.

Relationship between BODE index, quality of life and inflammatory cytokines in COPD patients.

Sarioglu N, Alpaydin AO, Coskun AS, Celik P, Ozyurt BC, Yorgancioglu A.

Multidiscip Respir Med. 2010 Apr 30;5(2):84-91. doi: 10.1186/2049-6958-5-2-84.

19.

C-reactive protein in patients with COPD, control smokers and non-smokers.

Pinto-Plata VM, Müllerova H, Toso JF, Feudjo-Tepie M, Soriano JB, Vessey RS, Celli BR.

Thorax. 2006 Jan;61(1):23-8. Epub 2005 Sep 2.

20.

Physical activity and longitudinal change in 6-min walk distance in COPD patients.

Frisk B, Espehaug B, Hardie JA, Strand LI, Moe-Nilssen R, Eagan TM, Bakke PS, Thorsen E.

Respir Med. 2014 Jan;108(1):86-94. doi: 10.1016/j.rmed.2013.09.004. Epub 2013 Sep 13.

PMID:
24075305
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk